Related Experiment Video
Updated: Jul 11, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion
Alon Barsheshet1, Ibrahim Marai, Shmulik Appel
1Heart Institute, Sheba Medical Center, and Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Abstract:
Intravenous immunoglobulin (IVIG) preparations are increasingly being used in the treatment of autoimmune disorders. This treatment is regarded as generally safe, and most of the adverse effects associated with IVIG administration are mild and transient. This paper reports a 72-year-old patient with known ischemic heart disease admitted for a Guillain-Barré syndrome variant, who developed acute ST elevation myocardial infarction (MI) during the first hours of IVIG infusion. The literature on acute MI during IVIG treatment is reviewed. Evaluation of each patient for cardiovascular risk prior to IVIG treatment is recommended as is the assessment of risk versus benefit. If IVIG is prescribed, we propose close monitoring and slow infusion rate.
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Coronary Syndrome I: Introduction
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
